Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
4.720
-0.500 (-9.58%)
Mar 31, 2025, 1:43 PM EDT - Market open
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $419.12 million as of March 31, 2025. Its market cap has decreased by -65.05% in one year.
Market Cap
419.12M
Enterprise Value
-25.41M
1-Year Change
-65.05%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $419.12M, a decrease of -51.79%. That is a compound annual growth rate of -17.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 463.51M | -2.93% |
| Dec 31, 2024 | 477.50M | -57.41% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.63B |
| UnitedHealth Group | 474.21B |
| Johnson & Johnson | 395.36B |
| AbbVie | 362.06B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.76B |
| Merck & Co. | 226.55B |
| AstraZeneca | 225.00B |